Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL10 Antikörper (AA 1-233)

BCL10 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5013223
  • Target Alle BCL10 Antikörper anzeigen
    BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
    Bindungsspezifität
    • 17
    • 15
    • 10
    • 9
    • 7
    • 7
    • 7
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-233
    Reaktivität
    • 104
    • 37
    • 15
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 75
    • 29
    Kaninchen
    Klonalität
    • 62
    • 43
    Polyklonal
    Konjugat
    • 48
    • 8
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BCL10 Antikörper ist unkonjugiert
    Applikation
    • 79
    • 34
    • 32
    • 32
    • 28
    • 20
    • 13
    • 13
    • 12
    • 11
    • 10
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against Bcl10. It has been selected for its ability to recognize Bcl10 in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography
    Immunogen
    Bcl10 (Met1-Gln233)
    Isotyp
    IgG
    Top Product
    Discover our top product BCL10 Primärantikörper
  • Applikationshinweise
    • Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
  • Target
    BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
    Abstract
    BCL10 Produkte
    Synonyme
    CARMEN antikoerper, CIPER antikoerper, CLAP antikoerper, c-E10 antikoerper, mE10 antikoerper, BCL10 antikoerper, AI132454 antikoerper, BCL-10 antikoerper, C81403 antikoerper, ME10 antikoerper, cE10 antikoerper, bcl10 antikoerper, B-cell CLL/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10-like antikoerper, B cell leukemia/lymphoma 10 antikoerper, B-cell lymphoma/leukemia 10 antikoerper, BCL10 antikoerper, Bcl10 antikoerper, bcl10 antikoerper, LOC100223183 antikoerper
    Hintergrund
    Alternative Names: CARMEN, CIPER, CLAP, c-E10, mE10, CARD-containing molecule enhancing NF-kappa-B, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN
    Pathways
    T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Sie sind hier:
Kundenservice